Consequently, we concluded that lncRNA GSEC acts as an oncogene in lung adenocarcinoma by targeting miR-873-3p to modulate EGLN3, which might be the mechanism of LUAD progression. This evidence concerns the gene EGLN3 and lung adenocarcinoma.